US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cartesian Therapeutics

10.04

-0.1900-1.86%

Post-market: 10.040.00000.00%19:37 EDT

Volume:163.90K

Turnover:1.68M

Market Cap:303.76M

PE:-1.73

High:10.69

Open:10.35

Low:10.00

Close:10.23

52wk High:11.80

52wk Low:5.60

Shares:30.26M

Float Shares:12.40M

Volume Ratio:0.86

T/O Rate:1.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.7983

EPS(LYR):-5.0200

ROE:-7029.26%

ROA:-17.43%

PB:-2.43

PE(LYR):-2.00

Loading ...

Overview Company News Filings

Cartesian Therapeutics Inc - Enters Loan and Security Agreement on May 22 - SEC Filing

THOMSON REUTERS

Cartesian Therapeutics secures up to $150 million credit facility from K2 HealthVentures

Cartesian Therapeutics Inc - Phase 3 Aurora Topline Data in Myasthenia Gravis Expected in 1Q27; Bla Filing Planned Mid-2027

THOMSON REUTERS

Cartesian Therapeutics Secures up to $150 Million of Non-Dilutive Financing From K2 Healthventures and Expects Topline Data From the Phase 3 Aurora Trial in First Quarter 2027

THOMSON REUTERS

Cartesian Therapeutics to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

Cartesian Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Cartesian Therapeutics grants 317,200 inducement stock options at $6.22 exercise price

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics Price Target Maintained With a $38.00/Share by Wedbush

Cantor Fitzgerald Keeps Their Buy Rating on Cartesian Therapeutics (RNAC)

Cartesian Therapeutics (RNAC) Gets a Buy from Wedbush

Cartesian Therapeutics Q1 EPS $(1.46) Misses $(0.88) Estimate, Sales $78.000K Miss $99.833K Estimate

Benzinga Earnings

Cartesian Therapeutics Inc Q1 Net Income USD -39.182 Million

Cartesian Therapeutics Q1 FY26 net loss widens to $39.2 million

Cartesian Therapeutics Inc Q1 Operating Expenses USD 26.577 Million

THOMSON REUTERS

Cartesian Therapeutics Inc Q1 Operating Income USD -26.499 Million

THOMSON REUTERS

Cartesian Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Cartesian Therapeutics management to meet with BTIG

Cartesian Therapeutics announces annual shareholder meeting

Buy Rating on Cartesian Therapeutics (RNAC) Driven by Strong Strategic Vision, Clinical Roadmap, and Attractive Risk‑Reward Profile

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/RNAC/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RNAC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNAC\",,,,,undefined,":{"symbol":"RNAC","market":"US","secType":"STK","nameCN":"Cartesian Therapeutics","latestPrice":10.04,"timestamp":1787342400000,"preClose":10.23,"halted":0,"volume":163904,"hourTrading":{"tag":"盘后","latestPrice":10.04,"preClose":10.04,"latestTime":"19:37 EDT","volume":482,"amount":4850.16,"timestamp":1787355428409,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.018572825024438053,"floatShares":12402686,"shares":30255400,"eps":-5.79826,"marketStatus":"Not Yet Opened","change":-0.19,"latestTime":"08-21 16:00:00 EDT","open":10.35,"high":10.69,"low":10,"amount":1681485.071552,"amplitude":0.067449,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.79826,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"listingDate":1466568000000,"exchange":"NASDAQ","adjPreClose":10.23,"preHourTrading":{"tag":"盘前","latestPrice":10.45,"preClose":10.23,"latestTime":"09:04 EDT","volume":504,"amount":5166.399672,"timestamp":1787317441899,"change":0.22,"changeRate":0.021505,"amplitude":0.144673},"postHourTrading":{"tag":"盘后","latestPrice":10.04,"preClose":10.04,"latestTime":"19:37 EDT","volume":482,"amount":4850.16,"timestamp":1787355428409,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8620963504397965,"impliedVol":0.5541,"impliedVolPercentile":0.2829},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNAC\",,,,,undefined,":{"symbol":"RNAC","floatShares":12402686,"roa":"-17.43%","roe":"-7029.26%","lyrEps":-5.02,"volumeRatio":0.8620963504397965,"shares":30255400,"dividePrice":0,"high":10.69,"amplitude":0.067449,"preClose":10.23,"low":10,"week52Low":5.6,"pbRate":"-2.43","psRate":"205.66","week52High":11.8,"institutionHeld":0,"latestPrice":10.04,"eps":-5.79826,"divideRate":0,"volume":163904,"delay":0,"ttmEps":-5.79826,"open":10.35,"prevYearClose":7.21,"prevWeekClose":8.84,"prevMonthClose":7.8,"prevQuarterClose":10.42,"fiveDayClose":8.84,"twentyDayClose":7.88,"sixtyDayClose":6.93},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNAC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"RNAC","fiscalQuarterEnding":"2026/06","expectedEps":-0.83,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":0.46},{"market":"US","date":"2026-04-30","symbol":"RNAC","fiscalQuarterEnding":"2026/03","expectedEps":-0.84,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"pre","actualEps":-1.46},{"market":"US","date":"2026-03-09","symbol":"RNAC","fiscalQuarterEnding":"2025/12","expectedEps":-0.82,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773028800000,"reportTimeType":"pre","actualEps":-1.38},{"market":"US","date":"2025-11-06","symbol":"RNAC","fiscalQuarterEnding":"2025/09","expectedEps":-0.81,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-1.38},{"market":"US","date":"2025-08-07","symbol":"RNAC","fiscalQuarterEnding":"2025/06","expectedEps":-0.76,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":0.5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNAC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNAC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.625,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1777608000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNAC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNAC","date":"2026-08-21","current":-1.731554,"percent":0.528271,"low":-14.109752,"twenty":-6.643213,"median":-2.087161,"eighty":-1.488739,"high":-0.322359,"avg":-3.646287,"sd":2.876251,"marketCap":309512250},"quantilePoints":[{"date":"2024-02-09","current":-12.195228,"twenty":-12.293822,"median":-12.139657,"eighty":-11.530164,"marketCap":110159496},{"date":"2024-02-16","current":-13.543282,"twenty":-12.82193,"median":-12.371802,"eighty":-12.018117,"marketCap":122336468},{"date":"2024-02-23","current":-12.9069,"twenty":-13.170416,"median":-12.72226,"eighty":-12.169773,"marketCap":116588031},{"date":"2024-03-01","current":-13.113052,"twenty":-13.187625,"median":-12.9069,"eighty":-12.193077,"marketCap":118450201},{"date":"2024-03-08","current":-0.474472,"twenty":-13.096919,"median":-12.72226,"eighty":-12.104521,"marketCap":104246325},{"date":"2024-03-15","current":-0.394571,"twenty":-13.085087,"median":-12.369113,"eighty":-0.499332,"marketCap":86691095},{"date":"2024-03-22","current":-0.518772,"twenty":-13.077916,"median":-12.18985,"eighty":-0.473381,"marketCap":113979437},{"date":"2024-03-28","current":-0.486782,"twenty":-13.018401,"median":-12.095738,"eighty":-0.472836,"marketCap":106950867},{"date":"2024-04-05","current":-0.371573,"twenty":-12.924109,"median":-11.522994,"eighty":-0.462369,"marketCap":81638284},{"date":"2024-04-12","current":-1.459867,"twenty":-12.9069,"median":-1.226402,"eighty":-0.444134,"marketCap":320747357},{"date":"2024-04-19","current":-1.398365,"twenty":-12.846668,"median":-1.459867,"eighty":-0.462369,"marketCap":307234719},{"date":"2024-04-26","current":-1.691309,"twenty":-12.729072,"median":-1.487381,"eighty":-0.467868,"marketCap":371597548},{"date":"2024-05-03","current":-1.978779,"twenty":-12.63227,"median":-1.536745,"eighty":-0.471303,"marketCap":434757574},{"date":"2024-05-10","current":-1.526348,"twenty":-12.47667,"median":-1.594687,"eighty":-0.472836,"marketCap":389021718},{"date":"2024-05-17","current":-1.839158,"twenty":-12.299559,"median":-1.62026,"eighty":-0.47633,"marketCap":468748036},{"date":"2024-05-24","current":-1.777713,"twenty":-12.193077,"median":-1.671483,"eighty":-0.482182,"marketCap":453087509},{"date":"2024-05-31","current":-2.195259,"twenty":-12.18985,"median":-1.697348,"eighty":-0.489671,"marketCap":559507906},{"date":"2024-06-07","current":-2.422885,"twenty":-12.179811,"median":-1.717665,"eighty":-0.504164,"marketCap":617523039},{"date":"2024-06-14","current":-2.045138,"twenty":-12.139657,"median":-1.777713,"eighty":-0.515905,"marketCap":521246392},{"date":"2024-06-21","current":-1.598266,"twenty":-12.069386,"median":-1.728138,"eighty":-0.518199,"marketCap":407351653},{"date":"2024-06-28","current":-1.991374,"twenty":-11.947846,"median":-1.777713,"eighty":-0.520305,"marketCap":507543431},{"date":"2024-07-05","current":-1.23169,"twenty":-11.531957,"median":-1.728138,"eighty":-0.526438,"marketCap":313922113},{"date":"2024-07-12","current":-1.241477,"twenty":-11.522994,"median":-1.709478,"eighty":-0.530124,"marketCap":316416386},{"date":"2024-07-15","current":-1.240079,"twenty":-9.729226,"median":-1.703386,"eighty":-0.53751,"marketCap":316060062},{"date":"2024-08-02","current":-1.081399,"twenty":-7.935458,"median":-1.699966,"eighty":-0.544895,"marketCap":275617201},{"date":"2024-08-09","current":-1.198323,"twenty":-2.548847,"median":-1.676743,"eighty":-0.772791,"marketCap":275192581},{"date":"2024-08-16","current":-1.345437,"twenty":-2.529995,"median":-1.625846,"eighty":-1.101689,"marketCap":308976908},{"date":"2024-08-23","current":-1.244878,"twenty":-2.507232,"median":-1.598266,"eighty":-1.148418,"marketCap":285883824},{"date":"2024-08-30","current":-1.388267,"twenty":-2.46827,"median":-1.531547,"eighty":-1.172903,"marketCap":318812851},{"date":"2024-09-06","current":-1.307262,"twenty":-2.424002,"median":-1.519153,"eighty":-1.173531,"marketCap":300210089},{"date":"2024-09-13","current":-1.496275,"twenty":-2.390626,"median":-1.497092,"eighty":-1.177113,"marketCap":343616533},{"date":"2024-09-20","current":-1.540036,"twenty":-2.248325,"median":-1.497406,"eighty":-1.182548,"marketCap":353666301},{"date":"2024-09-27","current":-1.616387,"twenty":-2.173184,"median":-1.49772,"eighty":-1.183457,"marketCap":371199939},{"date":"2024-10-04","current":-2.374287,"twenty":-2.173184,"median":-1.519153,"eighty":-1.187433,"marketCap":545250240},{"date":"2024-10-11","current":-2.176603,"twenty":-2.352646,"median":-1.530726,"eighty":-1.193387,"marketCap":499852543},{"date":"2024-10-18","current":-2.257757,"twenty":-2.310612,"median":-1.544226,"eighty":-1.200277,"marketCap":518489492},{"date":"2024-10-25","current":-2.299664,"twenty":-2.339564,"median":-1.569114,"eighty":-1.208188,"marketCap":528113202},{"date":"2024-10-31","current":-2.199769,"twenty":-2.325678,"median":-1.616387,"eighty":-1.208566,"marketCap":505172538},{"date":"2024-11-08","current":-2.028231,"twenty":-2.320475,"median":-1.625846,"eighty":-1.217877,"marketCap":496569789},{"date":"2024-11-15","current":-1.766791,"twenty":-2.31186,"median":-1.676743,"eighty":-1.221601,"marketCap":432561563},{"date":"2024-11-22","current":-1.725268,"twenty":-2.307988,"median":-1.693927,"eighty":-1.221601,"marketCap":422395604},{"date":"2024-11-29","current":-1.954681,"twenty":-2.306323,"median":-1.709478,"eighty":-1.229672,"marketCap":478562529},{"date":"2024-12-06","current":-2.388593,"twenty":-2.306323,"median":-1.725268,"eighty":-1.23169,"marketCap":584796802},{"date":"2024-12-13","current":-2.088591,"twenty":-2.321516,"median":-1.757967,"eighty":-1.238401,"marketCap":511347747},{"date":"2024-12-20","current":-2.024787,"twenty":-2.313583,"median":-1.76875,"eighty":-1.241197,"marketCap":495726646},{"date":"2024-12-27","current":-2.088883,"twenty":-2.309537,"median":-1.777713,"eighty":-1.243092,"marketCap":511419083},{"date":"2025-01-03","current":-1.778913,"twenty":-2.307156,"median":-1.777862,"eighty":-1.244452,"marketCap":435529430},{"date":"2025-01-10","current":-1.777862,"twenty":-2.305849,"median":-1.777862,"eighty":-1.244878,"marketCap":435272177},{"date":"2025-01-17","current":-1.989062,"twenty":-2.304427,"median":-1.779554,"eighty":-1.246554,"marketCap":486980042},{"date":"2025-01-24","current":-2.040548,"twenty":-2.299664,"median":-1.784789,"eighty":-1.253258,"marketCap":499585442},{"date":"2025-01-31","current":-2.036345,"twenty":-2.283748,"median":-1.80308,"eighty":-1.272811,"marketCap":498556430},{"date":"2025-02-07","current":-1.976453,"twenty":-2.276485,"median":-1.8278,"eighty":-1.28026,"marketCap":483893005},{"date":"2025-02-14","current":-1.999569,"twenty":-2.273364,"median":-1.845442,"eighty":-1.299813,"marketCap":489552573},{"date":"2025-02-21","current":-2.060513,"twenty":-2.263946,"median":-1.859179,"eighty":-1.303538,"marketCap":504473250},{"date":"2025-02-28","current":-1.892393,"twenty":-2.258524,"median":-1.87682,"eighty":-1.306703,"marketCap":463312761},{"date":"2025-03-07","current":-1.875581,"twenty":-2.211367,"median":-1.875581,"eighty":-1.307262,"marketCap":459196712},{"date":"2025-03-14","current":-5.557927,"twenty":-2.211367,"median":-1.881886,"eighty":-1.317995,"marketCap":430316947},{"date":"2025-03-21","current":-5.33039,"twenty":-2.277938,"median":-1.88594,"eighty":-1.323353,"marketCap":412700118},{"date":"2025-03-28","current":-4.805047,"twenty":-2.306323,"median":-1.893969,"eighty":-1.325512,"marketCap":372025970},{"date":"2025-04-04","current":-4.129128,"twenty":-2.32984,"median":-1.905491,"eighty":-1.337057,"marketCap":319693626},{"date":"2025-04-11","current":-3.466594,"twenty":-2.375387,"median":-1.926854,"eighty":-1.34432,"marketCap":268397566},{"date":"2025-04-17","current":-3.536863,"twenty":-2.423443,"median":-1.931271,"eighty":-1.357169,"marketCap":273838057},{"date":"2025-04-25","current":-4.03209,"twenty":-2.511189,"median":-1.940728,"eighty":-1.376163,"marketCap":312180567},{"date":"2025-05-02","current":-4.105705,"twenty":-2.552358,"median":-1.945456,"eighty":-1.384171,"marketCap":317880129},{"date":"2025-05-09","current":-7.05935,"twenty":-3.360856,"median":-1.954681,"eighty":-1.385102,"marketCap":270443712},{"date":"2025-05-16","current":-7.066125,"twenty":-3.485332,"median":-1.967259,"eighty":-1.38715,"marketCap":270703255},{"date":"2025-05-23","current":-6.195562,"twenty":-3.649293,"median":-1.975402,"eighty":-1.394326,"marketCap":237351991},{"date":"2025-05-30","current":-6.774808,"twenty":-3.931706,"median":-1.977504,"eighty":-1.416672,"marketCap":259542910},{"date":"2025-06-06","current":-6.327671,"twenty":-4.025398,"median":-1.983808,"eighty":-1.446219,"marketCap":242413077},{"date":"2025-06-13","current":-6.937404,"twenty":-4.149205,"median":-1.989062,"eighty":-1.451731,"marketCap":265771939},{"date":"2025-06-20","current":-6.774808,"twenty":-4.316511,"median":-1.991374,"eighty":-1.456219,"marketCap":259542910},{"date":"2025-06-27","current":-7.76393,"twenty":-4.826462,"median":-1.999044,"eighty":-1.463428,"marketCap":297436174},{"date":"2025-07-03","current":-7.59456,"twenty":-4.979046,"median":-2.003247,"eighty":-1.47767,"marketCap":290947602},{"date":"2025-07-11","current":-9.173091,"twenty":-5.33039,"median":-2.020584,"eighty":-1.478169,"marketCap":351421100},{"date":"2025-07-18","current":-8.488835,"twenty":-5.941507,"median":-2.024838,"eighty":-1.490688,"marketCap":325207266},{"date":"2025-07-25","current":-9.118892,"twenty":-6.287022,"median":-2.028231,"eighty":-1.49255,"marketCap":349344756},{"date":"2025-08-01","current":-8.67853,"twenty":-6.612213,"median":-2.031821,"eighty":-1.496275,"marketCap":332474467},{"date":"2025-08-08","current":-7.544353,"twenty":-6.70706,"median":-2.036345,"eighty":-1.497092,"marketCap":273558227},{"date":"2025-08-15","current":-8.196452,"twenty":-6.774808,"median":-2.042843,"eighty":-1.49772,"marketCap":297203340},{"date":"2025-08-22","current":-7.859415,"twenty":-6.950953,"median":-2.051056,"eighty":-1.50093,"marketCap":284982380},{"date":"2025-08-29","current":-7.371787,"twenty":-7.039026,"median":-2.060422,"eighty":-1.518941,"marketCap":267300991},{"date":"2025-09-05","current":-7.170999,"twenty":-7.05935,"median":-2.070182,"eighty":-1.51928,"marketCap":260020420},{"date":"2025-09-12","current":-7.142315,"twenty":-7.086783,"median":-2.081446,"eighty":-1.524951,"marketCap":258980338},{"date":"2025-09-19","current":-7.3933,"twenty":-7.086783,"median":-2.084663,"eighty":-1.52985,"marketCap":268081053},{"date":"2025-09-26","current":-6.783765,"twenty":-7.148052,"median":-2.088591,"eighty":-1.535541,"marketCap":245979317},{"date":"2025-10-03","current":-7.414813,"twenty":-7.201117,"median":-2.095187,"eighty":-1.539378,"marketCap":268861114},{"date":"2025-10-10","current":-7.242709,"twenty":-7.224056,"median":-2.14643,"eighty":-1.54674,"marketCap":262620624},{"date":"2025-10-17","current":-6.755081,"twenty":-7.209722,"median":-2.173618,"eighty":-1.557355,"marketCap":244939235},{"date":"2025-10-24","current":-6.453899,"twenty":-7.201117,"median":-2.199769,"eighty":-1.567209,"marketCap":234018378},{"date":"2025-10-31","current":-5.81568,"twenty":-7.176736,"median":-2.267478,"eighty":-1.592436,"marketCap":210876560},{"date":"2025-11-07","current":-4.091695,"twenty":-7.170999,"median":-2.283748,"eighty":-1.612763,"marketCap":196315417},{"date":"2025-11-14","current":-3.918507,"twenty":-7.148052,"median":-2.305763,"eighty":-1.619485,"marketCap":188006071},{"date":"2025-11-21","current":-3.875149,"twenty":-7.086783,"median":-2.31186,"eighty":-1.622774,"marketCap":185925782},{"date":"2025-11-28","current":-4.059422,"twenty":-7.068835,"median":-2.325678,"eighty":-1.626335,"marketCap":194767008},{"date":"2025-12-05","current":-3.739654,"twenty":-7.06451,"median":-2.365337,"eighty":-1.65105,"marketCap":179424881},{"date":"2025-12-12","current":-4.579722,"twenty":-7.060984,"median":-2.379788,"eighty":-1.672535,"marketCap":219730470},{"date":"2025-12-19","current":-3.988965,"twenty":-7.05935,"median":-2.423583,"eighty":-1.677012,"marketCap":191386540},{"date":"2025-12-26","current":-3.663777,"twenty":-7.058115,"median":-2.483579,"eighty":-1.682838,"marketCap":175784376},{"date":"2026-01-02","current":-3.907668,"twenty":-7.055526,"median":-2.5116,"eighty":-1.692356,"marketCap":187485999},{"date":"2026-01-09","current":-4.400869,"twenty":-7.049866,"median":-2.540887,"eighty":-1.697913,"marketCap":211149280},{"date":"2026-01-16","current":-3.988965,"twenty":-7.038171,"median":-2.581927,"eighty":-1.705823,"marketCap":191386540},{"date":"2026-01-23","current":-4.1082,"twenty":-7.03475,"median":-3.265826,"eighty":-1.71557,"marketCap":197107333},{"date":"2026-01-30","current":-3.783013,"twenty":-7.03475,"median":-3.400258,"eighty":-1.717665,"marketCap":181505169},{"date":"2026-02-06","current":-3.403628,"twenty":-7.025476,"median":-3.463248,"eighty":-1.725268,"marketCap":163302645},{"date":"2026-02-13","current":-3.474085,"twenty":-7.020408,"median":-3.474085,"eighty":-1.728138,"marketCap":166683114},{"date":"2026-02-20","current":-3.674617,"twenty":-7.019042,"median":-3.506604,"eighty":-1.751586,"marketCap":176304448},{"date":"2026-02-27","current":-4.525524,"twenty":-6.997119,"median":-3.520153,"eighty":-1.758278,"marketCap":217130110},{"date":"2026-03-06","current":-3.728815,"twenty":-6.991626,"median":-3.536863,"eighty":-1.76513,"marketCap":178904809},{"date":"2026-03-13","current":-1.651957,"twenty":-6.985963,"median":-3.528282,"eighty":-1.753846,"marketCap":215253274},{"date":"2026-03-20","current":-1.33662,"twenty":-6.957673,"median":-3.51344,"eighty":-1.717246,"marketCap":174164287},{"date":"2026-03-27","current":-1.236933,"twenty":-6.943412,"median":-3.490344,"eighty":-1.689135,"marketCap":161174865},{"date":"2026-04-02","current":-1.3,"twenty":-6.939053,"median":-3.46763,"eighty":-1.672535,"marketCap":169392663},{"date":"2026-04-10","current":-1.257277,"twenty":-6.933339,"median":-3.403628,"eighty":-1.622146,"marketCap":163825768},{"date":"2026-04-17","current":-1.297966,"twenty":-6.92426,"median":-3.364537,"eighty":-1.565304,"marketCap":169127573},{"date":"2026-04-24","current":-1.417997,"twenty":-6.914189,"median":-2.609701,"eighty":-1.534337,"marketCap":184767897},{"date":"2026-05-01","current":-1.086392,"twenty":-6.894617,"median":-2.546025,"eighty":-1.512742,"marketCap":164886129},{"date":"2026-05-08","current":-1.579672,"twenty":-6.838981,"median":-2.513656,"eighty":-1.499646,"marketCap":239753154},{"date":"2026-05-15","current":-1.600967,"twenty":-6.793804,"median":-2.483579,"eighty":-1.502438,"marketCap":242985120},{"date":"2026-05-22","current":-1.293163,"twenty":-6.778391,"median":-2.422885,"eighty":-1.494785,"marketCap":196268513},{"date":"2026-05-29","current":-1.395764,"twenty":-6.774808,"median":-2.379788,"eighty":-1.483177,"marketCap":211840715},{"date":"2026-06-05","current":-1.267997,"twenty":-6.772654,"median":-2.365337,"eighty":-1.459736,"marketCap":192448916},{"date":"2026-06-12","current":-1.560313,"twenty":-6.766157,"median":-2.325678,"eighty":-1.446219,"marketCap":236815002},{"date":"2026-06-18","current":-1.912642,"twenty":-6.761259,"median":-2.31186,"eighty":-1.450539,"marketCap":290289358},{"date":"2026-06-26","current":-1.728734,"twenty":-6.760023,"median":-2.305763,"eighty":-1.456175,"marketCap":262376920},{"date":"2026-07-02","current":-1.970718,"twenty":-6.755081,"median":-2.291706,"eighty":-1.459648,"marketCap":299103812},{"date":"2026-07-10","current":-1.871989,"twenty":-6.755081,"median":-2.273364,"eighty":-1.459867,"marketCap":284119240},{"date":"2026-07-17","current":-1.612582,"twenty":-6.70706,"median":-2.228763,"eighty":-1.46072,"marketCap":244748011},{"date":"2026-07-24","current":-1.533211,"twenty":-6.70706,"median":-2.176603,"eighty":-1.47767,"marketCap":232701590},{"date":"2026-07-31","current":-1.49643,"twenty":-6.688109,"median":-2.155028,"eighty":-1.47428,"marketCap":227119103},{"date":"2026-08-07","current":-1.694518,"twenty":-6.664384,"median":-2.120969,"eighty":-1.478069,"marketCap":257382062},{"date":"2026-08-14","current":-1.736947,"twenty":-6.655677,"median":-2.088883,"eighty":-1.480388,"marketCap":263826669},{"date":"2026-08-21","current":-2.037726,"twenty":-6.643213,"median":-2.087161,"eighty":-1.488739,"marketCap":309512250}],"updateTime":1787503841968},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNAC\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638516700","title":"Cartesian Therapeutics Inc - Enters Loan and Security Agreement on May 22 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2638516700","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638516700?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:09","pubTimestamp":1779793785,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nFWN4230FR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638151614","title":"Cartesian Therapeutics secures up to $150 million credit facility from K2 HealthVentures","url":"https://stock-news.laohu8.com/highlight/detail?id=2638151614","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638151614?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:01","pubTimestamp":1779793306,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics entered a credit facility with K2 HealthVentures for up to USD 150 million in non-dilutive financing.USD 50 million initial term loan funded at signing; proceeds extend cash runway into 2028.Second USD 25 million tranche available Jan. 1–Dec. 1, 2027, subject to specified clinical and financing milestones.Third USD 25 million tranche available Jan. 1–June 1, 2028, subject to specified approval and sales milestones.Additional USD 50 million tranche available at Cartesian’s option, subject to K2 HealthVentures’ discretion.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL5CbYzR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014039.USD","BK4585","LU2210149790.SGD","BK4139","RNAC","IE00BN0W2V16.EUR","BK4112","BK4588","IE00B64PRP62.GBP","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2095319765.USD","NDAQ","SG9999014005.SGD","IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638516957","title":"Cartesian Therapeutics Inc - Phase 3 Aurora Topline Data in Myasthenia Gravis Expected in 1Q27; Bla Filing Planned Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2638516957","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638516957?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:00","pubTimestamp":1779793201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA2KTJ9Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638516687","title":"Cartesian Therapeutics Secures up to $150 Million of Non-Dilutive Financing From K2 Healthventures and Expects Topline Data From the Phase 3 Aurora Trial in First Quarter 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2638516687","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638516687?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:00","pubTimestamp":1779793201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA2KTJ9Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634213717","title":"Cartesian Therapeutics to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ","url":"https://stock-news.laohu8.com/highlight/detail?id=2634213717","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634213717?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:00","pubTimestamp":1778583600,"startTime":"0","endTime":"0","summary":"FREDERICK, Md., May  12, 2026  (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune disea","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3292640/0/en/Cartesian-Therapeutics-to-Participate-in-the-H-C-Wainwright-4th-Annual-BioConnect-Investor-Conference-at-NASDAQ.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVIW.SI","MNQmain","QDTE","NQmain","QLD","JEPQ",".IXIC","QQQJ","SQQQ","QQQA","QID","TQQY","QYLG","QQQM","RNAC","FTEC","TQQQ","PSQ","BK4139","TECS","QQQE","QQQY","ONEQ","QQQ","NDX","GPIQ","IYW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634290283","title":"Cartesian Therapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2634290283","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634290283?lang=en_us&edition=fundamental","pubTime":"2026-05-12 18:42","pubTimestamp":1778582520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RNAC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 12, 2026 06:42 ET (10:42 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632937173","title":"Cartesian Therapeutics grants 317,200 inducement stock options at $6.22 exercise price","url":"https://stock-news.laohu8.com/highlight/detail?id=2632937173","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632937173?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:06","pubTimestamp":1777892803,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics granted stock options covering 317,200 common shares to five newly hired employees under its Amended and Restated 2018 Employment Inducement Incentive Award Plan.Options carry an exercise price of USD 6.22, set at Nasdaq closing price on May 1, 2026.Vesting set at 25% on May 1, 2027, then monthly installments through May 1, 2030; options run for 10 years.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDLPQS97:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","RNAC","IE00BKPKM429.USD","SG9999014039.USD","IE00BGHQF748.EUR","LU2210149790.SGD","NDAQ","IE00BN0W2V16.EUR","LU2210150020.SGD","LU2095319765.USD","BK4585","IE00B3QW5Z07.USD","BK4139","IE00BN0W2T93.GBP","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2W23.USD","BK4588","IE00B64PRP62.GBP","SG9999014021.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632930309","title":"Cartesian Therapeutics Announces New Employment Inducement Grants","url":"https://stock-news.laohu8.com/highlight/detail?id=2632930309","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632930309?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:05","pubTimestamp":1777892700,"startTime":"0","endTime":"0","summary":"FREDERICK, Md., May  04, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune diseas","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/04/3286573/0/en/Cartesian-Therapeutics-Announces-New-Employment-Inducement-Grants.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632645924","title":"Cartesian Therapeutics Price Target Maintained With a $38.00/Share by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2632645924","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632645924?lang=en_us&edition=fundamental","pubTime":"2026-05-02 00:02","pubTimestamp":1777651320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RNAC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 01, 2026 12:02 ET (16:02 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632648182","title":"Cantor Fitzgerald Keeps Their Buy Rating on Cartesian Therapeutics (RNAC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632648182","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632648182?lang=en_us&edition=fundamental","pubTime":"2026-05-01 22:37","pubTimestamp":1777646276,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Cartesian Therapeutics, with a price target of $16...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-keeps-their-buy-rating-on-cartesian-therapeutics-rnac-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-keeps-their-buy-rating-on-cartesian-therapeutics-rnac-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632123436","title":"Cartesian Therapeutics (RNAC) Gets a Buy from Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2632123436","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632123436?lang=en_us&edition=fundamental","pubTime":"2026-05-01 20:39","pubTimestamp":1777639182,"startTime":"0","endTime":"0","summary":"In a report released today, Martin Fan from Wedbush maintained a Buy rating on Cartesian Therapeutics, with a price target of $38.00. Fan covers th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cartesian-therapeutics-rnac-gets-a-buy-from-wedbush-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cartesian-therapeutics-rnac-gets-a-buy-from-wedbush-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631276636","title":"Cartesian Therapeutics Q1 EPS $(1.46) Misses $(0.88) Estimate, Sales $78.000K Miss $99.833K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2631276636","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631276636?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:19","pubTimestamp":1777547976,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics (NASDAQ:RNAC) reported quarterly losses of $(1.46) per share which missed the analyst consensus estimate of $(0.88) by 65.91 percent. This is a 114.71 percent decrease over losses of $(0.68) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/04/52165293/cartesian-therapeutics-q1-eps-1-46-misses-0-88-estimate-sales-78-000k-miss-99-833k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631636548","title":"Cartesian Therapeutics Inc Q1 Net Income USD -39.182 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631636548","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631636548?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:12","pubTimestamp":1777547560,"startTime":"0","endTime":"0","summary":"Apr 30 (Reuters) - Cartesian Therapeutics Inc Q1 collaboration revenue USD 78 thousand.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 30-APR-202610:59:11.847 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nRSDQRFDN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631635091","title":"Cartesian Therapeutics Q1 FY26 net loss widens to $39.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631635091","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631635091?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:08","pubTimestamp":1777547295,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics posted a net loss of USD 39.2 million, more than doubling from year-ago levels.Operating loss widened 21.05% to USD 26.5 million.Research and development expense climbed 32.56% to USD 19.5 million, driven by higher costs for Phase 3 AURORA in myasthenia gravis.Enrollment progressed in Phase 3 AURORA for Descartes-08 in MG, while Phase 2 TRITON in dermatomyositis and antisynthetase syndrome was initiated and multiple patients enrolled in Phase 1/2 HELIOS in juvenile dermatomyositis.Cash, cash equivalents and restricted cash totaled USD 120.4 million at March 31, 2026, expected to fund operations into mid-2027 including completion of Phase 3 AURORA.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL1gFPyj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014005.SGD","IE00BKPKM429.USD","BK4588","LU0314104364.USD","LU2095319765.USD","BK4585","BK4139","IE00BN0W2V16.EUR","RNAC","LU2210150020.SGD","NDAQ","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4112","IE00BN0W2W23.USD","SG9999014039.USD","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631635877","title":"Cartesian Therapeutics Inc Q1 Operating Expenses USD 26.577 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631635877","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631635877?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:00","pubTimestamp":1777546804,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nPLXD05999:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631633069","title":"Cartesian Therapeutics Inc Q1 Operating Income USD -26.499 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631633069","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631633069?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:00","pubTimestamp":1777546804,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nPLXD05999:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631406636","title":"Cartesian Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2631406636","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631406636?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:00","pubTimestamp":1777546800,"startTime":"0","endTime":"0","summary":"Enrollment continues to progress in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis Phase 2 TRITON trial of Descartes-08 in dermatomyositis and antisynthetase syndrome initiated Multiple pat","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/30/3284688/0/en/Cartesian-Therapeutics-Reports-First-Quarter-2026-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","IE00B66KJ199.SGD","MG","IE00B7SZL793.SGD","IE0031619046.USD","RNAC","IE00B19Z4B17.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630158529","title":"Cartesian Therapeutics management to meet with BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2630158529","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630158529?lang=en_us&edition=fundamental","pubTime":"2026-04-28 22:36","pubTimestamp":1777386970,"startTime":"0","endTime":"0","summary":"Meeting to be held in New York on April 30 at 6 pm hosted by BTIG. Published first on TheFly – the ultimate source for real-time, market-moving bre...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cartesian-therapeutics-management-to-meet-with-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cartesian-therapeutics-management-to-meet-with-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630306175","title":"Cartesian Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2630306175","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630306175?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:33","pubTimestamp":1777376026,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics scheduled 2026 annual stockholder meeting for June 12, 2026 in virtual format.Ballot includes election of three Class I directors, with terms running to 2029.Stockholders will vote on an advisory resolution on named executive officer compensation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cartesian Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 28, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL1hsfVT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627448466","title":"Buy Rating on Cartesian Therapeutics (RNAC) Driven by Strong Strategic Vision, Clinical Roadmap, and Attractive Risk‑Reward Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2627448466","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627448466?lang=en_us&edition=fundamental","pubTime":"2026-04-14 19:17","pubTimestamp":1776165431,"startTime":"0","endTime":"0","summary":"Analyst Gil Blum of Needham maintained a Buy rating on Cartesian Therapeutics, retaining the price target of $42.00. Gil Blum has given his Buy rat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-on-cartesian-therapeutics-rnac-driven-by-strong-strategic-vision-clinical-roadmap-and-attractive-risk‑reward-profile-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-on-cartesian-therapeutics-rnac-driven-by-strong-strategic-vision-clinical-roadmap-and-attractive-risk‑reward-profile-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNAC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":78,"code":"91000000","status":"200"}]}}